ACADIA Pharmaceuticals

ACADIA Pharmaceuticals

Committed to developing treatments for neurological disorders.

Launch date
Employees
Market cap
AUD4.2b
Enterprise valuation
AUD3.5b (Public information from Sep 2024)
San Diego California (HQ)
Authorizing premium user...